Sino Biopharmaceutical | 1177 - Fremdkapital

Aktienkurs
5.42
Täglich Wechseln
-0.04 -0.73%
Monatlich
-7.98%
Jährlich
36.52%
Q2 Prognose
5.50




Fremdkapital Veränderung Datum
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Jiangsu Hengrui CNY 37.1M 6.2M 2026-03
Moderna USD 610M 584M 2025-12
Organon & Co USD 8.63B 155M 2025-12
Revvity USD 2.63B 543K 2025-12
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12